ATG3 and hepatocellular carcinoma: Results from sphere formation, in vitro, and in vivo limiting dilution assays revealed that silencing of ATG3 significantly impaired the inhibitory effects of betaine on the stem cell-like properties of HCC cells (Figure 8A-B and Figure S11A-D).